Aspiriant LLC’s Parker-Hannifin PH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$606K Buy
619
+207
+50% +$190K 0.02% 217
2026
Q1
$369K Sell
412
-19
-4% -$18K 0.01% 252
2025
Q4
$379K Sell
431
-12
-3% -$9.82K 0.01% 247
2025
Q3
$336K Sell
443
-19
-4% -$14K 0.01% 239
2025
Q2
$323K Sell
462
-12
-3% -$7.58K 0.01% 242
2025
Q1
$288K Sell
474
-11
-2% -$7.19K 0.01% 241
2024
Q4
$308K Buy
485
+36
+8% +$23.8K 0.01% 235
2024
Q3
$284K Sell
449
-112
-20% -$63.6K 0.01% 240
2024
Q2
$284K Sell
561
-111
-17% -$59.5K 0.01% 236
2024
Q1
$373K Sell
672
-27
-4% -$13.7K 0.02% 227
2023
Q4
$322K Sell
699
-130
-16% -$54.1K 0.01% 230
2023
Q3
$323K Buy
829
+261
+46% +$105K 0.02% 214
2023
Q2
$222K Buy
+568
New +$192K 0.01% 263
2022
Q1
Sell
-687
Closed -$219K 296
2021
Q4
$219K Buy
+687
New +$213K 0.01% 259

Other funds holding PH

Aspiriant LLC's PH Position: Q2 2026 in Review

Aspiriant LLC increased its Parker-Hannifin (PH) stake by 50% in Q2 2026, buying an estimated $190K and bringing the position to 619 shares worth $606K. The position accounts for 0.02% of the portfolio, ranked #217.

Aspiriant LLC first reported a position in PH in Q4 2021 and has held it in 14 quarters since. 396 funds tracked by Wall St. Rank hold PH as of Q2 2026.

  • Aspiriant LLC held 619 shares of Parker-Hannifin worth $606K as of Q2 2026.
  • Aspiriant LLC bought 207 Parker-Hannifin shares in Q2 2026, an estimated $190K.
  • Parker-Hannifin made up 0.02% of Aspiriant LLC's portfolio in Q2 2026, its #217 holding.
  • Aspiriant LLC first reported a position in Parker-Hannifin in Q4 2021 and has held it in 14 quarters since.
  • 396 funds tracked by Wall St. Rank held Parker-Hannifin as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.